C H Turner
Overview
Explore the profile of C H Turner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
5717
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fu B, An W, Turner C, Thompson G
Phys Rev Lett
. 2010 Sep;
105(9):096101.
PMID: 20868177
The in situ growth stress and postgrowth stress relaxation during the L1(0) chemical ordering of Fe0.54Pt0.46 thin films have been characterized. The compressive stress is reduced with an increase in...
2.
Li J, Zhao L, Ferries I, Jiang L, Desta M, Yu X, et al.
J Musculoskelet Neuronal Interact
. 2010 Jun;
10(2):180-7.
PMID: 20516636
This study aimed to understand the role of Cav1.3, one of the four L-type voltage sensitive calcium channels (VSCC) alpha(1) subunits, in the skeletal response to mechanical loading and intermittent...
3.
Havill L, Allen M, Bredbenner T, Burr D, Nicolella D, Turner C, et al.
Bone
. 2009 Nov;
46(3):835-40.
PMID: 19900599
Genetic effects on mechanical properties have been demonstrated in rodents, but not confirmed in primates. Our aim was to quantify the proportion of variation in vertebral trabecular bone mechanical properties...
4.
Niziolek P, Murthy S, Ellis S, Sukhija K, Hornberger T, Turner C, et al.
J Cell Physiol
. 2009 Jul;
221(3):579-85.
PMID: 19639601
The osteo-anabolic effects of intermittent parathyroid hormone (PTH) treatment require insulin-like growth factor (IGF) signaling through the IGF-I receptor. A major downstream target of the IGF-I receptor (via Akt) is...
5.
Smith S, Jolette J, Turner C
Am J Primatol
. 2009 Jun;
71(9):752-65.
PMID: 19492409
Currently, the nonhuman primate is the most widely used large animal model to evaluate the safety and efficacy of new drug entities to treat or prevent estrogen-deficiency-induced bone loss and...
6.
7.
Andresen C, Moalli M, Turner C, Berryman E, Pero R, Bagi C
Calcif Tissue Int
. 2008 Nov;
83(6):393-403.
PMID: 19018584
Intermittent combination of an anabolic agent to promote bone formation and an antiresorptive agent that would prevent further bone loss is a theoretically attractive approach for restoring bone mass. We...
8.
Fox J, NEWMAN M, Turner C, Guldberg R, Varela A, Smith S
Calcif Tissue Int
. 2008 Feb;
82(3):212-20.
PMID: 18297227
Osteoporosis is characterized by impaired bone quality leading to increased susceptibility to fracture, particularly of the thoracic spine. However, the lumbar spine is studied most commonly. We investigated the effects...
9.
Welch J, Turner C, Devareddy L, Arjmandi B, Weaver C
Bone
. 2008 Feb;
42(4):660-8.
PMID: 18291744
The benefits of impact exercise and dietary calcium on bone development are controversial. We used inbred rats under highly controlled conditions to test the independent and combined effects of impact...
10.
Turner C
J Musculoskelet Neuronal Interact
. 2007 Dec;
7(4):342-3.
PMID: 18094504
No abstract available.